176 related articles for article (PubMed ID: 32537935)
21. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of the advanced lung cancer inflammation index in early-stage non-small cell lung cancer patients undergoing video-assisted thoracoscopic pulmonary resection.
Wang Y; Lin L; Ji Y; Mei X; Zhao C; Chen Y; Che G
Ann Palliat Med; 2020 May; 9(3):721-729. PubMed ID: 32312059
[TBL] [Abstract][Full Text] [Related]
23. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
24. Use of the Advanced Lung Cancer Inflammation Index as a Prognostic Indicator for Patients With Cholangiocarcinoma.
Wu H; Ding F; Lin M; Shi Z; Mei Z; Chen S; Jiang C; Qiu H; Zheng Z; Chen Y; Zhao P
Front Surg; 2022; 9():801767. PubMed ID: 35155556
[TBL] [Abstract][Full Text] [Related]
25. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
26. Combination of Advanced Lung Cancer Inflammation Index and C-Reactive Protein Is a Prognostic Factor in Patients With Operable Non-Small Cell Lung Cancer.
Tomita M; Ayabe T; Maeda R; Nakamura K
World J Oncol; 2017 Dec; 8(6):175-179. PubMed ID: 29317962
[TBL] [Abstract][Full Text] [Related]
27. The Predictive Significance of the Advanced Lung Cancer Inflammation Index (ALI) in Patients with Melanoma Treated with Immunotherapy as Second-Line Therapy.
Cheng X; Dong Y; Lou F
Cancer Manag Res; 2021; 13():173-180. PubMed ID: 33469361
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy.
Topkan E; Mertsoylu H; Ozdemir Y; Sezer A; Kucuk A; Besen AA; Ozyilkan O; Selek U
Cancer Manag Res; 2019; 11():8807-8815. PubMed ID: 31632140
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of advanced lung cancer inflammation index in patients with colorectal cancer liver metastases undergoing surgery.
Pian G; Hong SY; Oh SY
Tumori; 2022 Feb; 108(1):56-62. PubMed ID: 33393453
[TBL] [Abstract][Full Text] [Related]
30. Clinical implication of the advanced lung cancer inflammation index in patients with right-sided colon cancer after complete mesocolic excision: a propensity score-matched analysis.
Deng Y; Sun Y; Lin Y; Huang Y; Chi P
World J Surg Oncol; 2022 Aug; 20(1):246. PubMed ID: 35909159
[TBL] [Abstract][Full Text] [Related]
31. The advanced lung cancer inflammation index predicts short and long-term outcomes in patients with colorectal cancer following surgical resection: a retrospective study.
Xie H; Huang S; Yuan G; Kuang J; Yan L; Wei L; Tang S; Gan J
PeerJ; 2020; 8():e10100. PubMed ID: 33083140
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer.
Cetin S; Dede I
J Cancer Res Ther; 2020; 16(4):909-916. PubMed ID: 32930139
[TBL] [Abstract][Full Text] [Related]
33. Handgrip weakness, systemic inflammation indicators, and overall survival in lung cancer patients with well performance status: A large multicenter observational study.
Song M; Zhang Q; Song C; Liu T; Zhang X; Ruan G; Tang M; Zhang X; Xie H; Zhang H; Ge Y; Li X; Zhang K; Yang M; Li Q; Liu X; Lin S; Xu Y; Li B; Li X; Wang K; Xu H; Li W; Shi H
Cancer Med; 2023 Feb; 12(3):2818-2830. PubMed ID: 36073671
[TBL] [Abstract][Full Text] [Related]
34. Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer.
Zhang K; Hua YQ; Wang D; Chen LY; Wu CJ; Chen Z; Liu LM; Chen H
J Transl Med; 2019 Jan; 17(1):30. PubMed ID: 30658662
[TBL] [Abstract][Full Text] [Related]
35. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients with Pathological Stage IA Lung Adenocarcinoma Following Surgical Resection.
Kobayashi S; Karube Y; Inoue T; Araki O; Maeda S; Matsumura Y; Chida M
Ann Thorac Cardiovasc Surg; 2019 Apr; 25(2):87-94. PubMed ID: 30333361
[TBL] [Abstract][Full Text] [Related]
36. The value of the Advanced Lung Cancer Inflammation Index (ALI) in assessing the prognosis of patients with hepatocellular carcinoma treated with camrelizumab: a retrospective cohort study.
Li Q; Ma F; Tsilimigras DI; Åberg F; Wang JF
Ann Transl Med; 2022 Nov; 10(22):1233. PubMed ID: 36544677
[TBL] [Abstract][Full Text] [Related]
37. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?
Sert F; Cosgun G; Yalman D; Ozkok S
Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415
[TBL] [Abstract][Full Text] [Related]
38. Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy.
Topkan E; Ozdemir Y; Kucuk A; Guler OC; Sezer A; Besen AA; Mertsoylu H; Senyurek S; Kilic Durankus N; Bolukbasi Y; Selek U; Pehlivan B
J Oncol; 2020; 2020():3127275. PubMed ID: 33082783
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy.
Chantharakhit C; Sujaritvanichpong N
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1149-1156. PubMed ID: 33906307
[TBL] [Abstract][Full Text] [Related]
40. Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer.
Fang L; Yan FH; Liu C; Chen J; Wang D; Zhang CH; Lou CJ; Lian J; Yao Y; Wang BJ; Li RY; Han SL; Bai YB; Yang JN; Li ZW; Zhang YQ
Cancer Res Treat; 2021 Jan; 53(1):131-139. PubMed ID: 32854494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
